Inventor · disambiguated record
Shelley K. Ballentine
Also filed as: BALLENTINE SHELLEY · BALLENTINE SHELLEY K
23 granted patents·203 citations·filing 2003–2015
95Inventor score
Top patents by PatentIndex Score
23 records- 0197US7645755B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jan 12, 2010·45 cites·7 claims
- 0295US7973035B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jul 5, 2011·24 cites·12 claims
- 0393US7795279B2Method of inhibiting FLT3 kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 14, 2010·30 cites·2 claims
- 0492US7662837B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 16, 2010·26 cites·22 claims
- 0587US7138530B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Nov 21, 2006·29 cites·48 claims
- 0684US8895584B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 25, 2014·4 cites·16 claims
- 0784US8859602B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2007·Granted Oct 14, 2014·4 cites·11 claims
- 0884US8815867B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2007·Granted Aug 26, 2014·4 cites·9 claims
- 0983US7109354B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Sep 19, 2006·17 cites·16 claims
- 1079US9296726B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Mar 29, 2016·2 cites·7 claims
- 1178US7482376B2Conjugated complement cascade inhibitorsDIMENSIONAL PHARM INC·Filed 2004·Granted Jan 27, 2009·11 cites·11 claims
- 1277US8481564B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2011·Granted Jul 9, 2013·2 cites·19 claims
- 1376US9221797B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 29, 2015·2 cites·18 claims
- 1476US7705042B2Class of arylamide compounds useful as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 27, 2010·3 cites·11 claims
- 1568US9526731B2Method of inhibiting C-KIT kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 27, 2016·0 cites·1 claims
- 1667US9403804B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 2, 2016·0 cites·11 claims
- 1767US9394289B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 19, 2016·0 cites·9 claims
- 1864US8933091B2Method of inhibiting C-KIT kinaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 13, 2015·0 cites·1 claims
- 1958US7868023B2Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditionsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jan 11, 2011·0 cites·17 claims
- 2056US8674100B2Inhibitors of C-FMS kinaseILLIG CARL R·Filed 2007·Granted Mar 18, 2014·0 cites·24 claims
- 2152US7385066B2Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditionsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 10, 2008·0 cites·12 claims
- 2251US9452996B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 27, 2016·0 cites·16 claims
- 2350US8232409B2Heterocyclic benzimidazoles as TRPM8 modulatorsPLAYER MARK R·Filed 2009·Granted Jul 31, 2012·0 cites·40 claims
Join the waitlist — get patent alerts
Get an alert when Shelley K. Ballentine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →